Top

Intensive Care Medicine

Published in:

01-11-2020 | Acute Respiratory Distress-Syndrome | Letter

Steroids in ARDS: more light is being shed

Authors: Nishkantha Arulkumaran, Timothy Arthur Chandos Snow, Alessia Longobardo, David Brealey, Mervyn Singer

Published in: Intensive Care Medicine | Issue 11/2020

Excerpt

Dear Editor, …

Available only for authorised users

RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ (2020) Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med. https://doi.org/10.1056/NEJMoa2021436CrossRef

Ni YN, Chen G, Sun J, Liang BM, Liang ZA (2019) The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Crit Care 23(1):99CrossRef

Jalkanen J, Pettila V, Huttunen T, Hollmen M, Jalkanen S (2020) Glucocorticoids inhibit type I IFN beta signaling and the upregulation of CD73 in human lung. Intensive Care Med. https://doi.org/10.1007/s00134-020-06086-3CrossRef

Stockman LJ, Bellamy R, Garner P (2006) SARS: systematic review of treatment effects. PLoS Med 3(9):e343CrossRef

Arabi YM, Mandourah Y, Al-Hameed F, Sindi AA, Almekhlafi GA, Hussein MA, Jose J, Pinto R, Al-Omari A, Kharaba A, Almotairi A, Al Khatib K, Alraddadi B, Shalhoub S, Abdulmomen A, Qushmaq I, Mady A, Solaiman O, Al-Aithan AM, Al-Raddadi R, Ragab A, Balkhy HH, Al Harthy A, Deeb AM, Al Mutairi H, Al-Dawood A, Merson L, Hayden FG, Fowler R, Saudi Critical Care Trial, Group (2018) A Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 197(6):757–767CrossRef

Torres A, Chalmers JD, Dela Cruz CS, Dominedo C, Kollef M, Martin-Loeches I, Niederman M, Wunderink RG (2019) Challenges in severe community-acquired pneumonia: a point-of-view review. Intensive Care Med 45(2):159–171CrossRef

Torres A, Ferrer M, Niederman MS (2018) Adjuvant therapies in critical care: steroids in community-acquired pneumonia. Intensive Care Med 44(4):478–481CrossRef

WHO Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. 2020. https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed on 26 June 2020

Alhazzani W, Moller MH, Arabi YM, Loeb M, Gong MN, Fan E, Oczkowski S, Levy MM, Derde L, Dzierba A, Du B, Aboodi M, Wunsch H, Cecconi M, Koh Y, Chertow DS, Maitland K, Alshamsi F, Belley-Cote E, Greco M, Laundy M, Morgan JS, Kesecioglu J, McGeer A, Mermel L, Mammen MJ, Alexander PE, Arrington A, Centofanti JE, Citerio G, Baw B, Memish ZA, Hammond N, Hayden FG, Evans L, Rhodes A (2020) Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 46(5):854–887CrossRef

10.

Preston IR, Sagliani KD, Warburton RR, Hill NS, Fanburg BL, Jaffe IZ (2013) Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 304(10):L678–L688CrossRef

11.

Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ Jr (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23(8):1430–1439CrossRef

12.

To KK, Tsang OT, Leung WS, Tam AR, Wu TC, Lung DC, Yip CC, Cai JP, Chan JM, Chik TS, Lau DP, Choi CY, Chen LL, Chan WM, Chan KH, Ip JD, Ng AC, Poon RW, Luo CT, Cheng VC, Chan JF, Hung IF, Chen Z, Chen H, Yuen KY (2020) Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study. Lancet Infect Dis 20(5):565–574CrossRef

13.

Bernard GR, Luce JM, Sprung CL, Rinaldo JE, Tate RM, Sibbald WJ, Kariman K, Higgins S, Bradley R, Metz CA et al (1987) High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 317(25):1565–1570CrossRef

14.

Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 280(2):159–165CrossRef

15.

Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M (2006) National heart, lung, and blood institute acute respiratory distress syndrome clinical trials, network efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354(16):1671–1684CrossRef

16.

Meduri GU, Golden E, Freire AX, Taylor E, Zaman M, Carson SJ, Gibson M, Umberger R (2007) Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 131(4):954–963CrossRef

17.

Liu L, Li J, Huang YZ, Liu SQ, Yang CS, Guo FM, Qiu HB, Yang Y (2012) The effect of stress dose glucocorticoid on patients with acute respiratory distress syndrome combined with critical illness-related corticosteroid insufficiency. Zhonghua Nei Ke Za Zhi 51(8):599–603

18.

Rezk A, Mohamed Ibrahim A (2013) Effects of methyl prednisolone in early ARDS. Egypt J Chest Dis Tuberc 62:5

19.

Tongyoo S, Permpikul C, Mongkolpun W, Vattanavanit V, Udompanturak S, Kocak M, Meduri GU (2016) Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial. Crit Care 20(1):329CrossRef

20.

Villar J, Ferrando C, Martinez D, Ambros A, Munoz T, Soler JA, Aguilar G, Alba F, Gonzalez-Higueras E, Conesa LA, Martin-Rodriguez C, Diaz-Dominguez FJ, Serna-Grande P, Rivas R, Ferreres J, Belda J, Capilla L, Tallet A, Anon JM, Fernandez RL, Gonzalez-Martin JM, Dexamethasone in, Ards network (2020) Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respir Med 8(3):267–276CrossRef

Title: Steroids in ARDS: more light is being shed
Authors: Nishkantha Arulkumaran
Timothy Arthur Chandos Snow
Alessia Longobardo
David Brealey
Mervyn Singer
Publication date: 01-11-2020
Publisher: Springer Berlin Heidelberg
Keywords: Acute Respiratory Distress-Syndrome
COVID-19
Dexamethasone
Prednisolone
Published in: Intensive Care Medicine / Issue 11/2020
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-020-06230-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Steroids in ARDS: more light is being shed

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2020

Less is more: critically ill status is not a carte blanche for unlimited antibiotic use

Access to intensive care in 14 European countries: a spatial analysis of intensive care need and capacity in the light of COVID-19

Direct evidence of SARS-CoV-2 in gut endothelium

The ten reasons why corticosteroid therapy reduces mortality in severe COVID-19

Oral water ingestion in the treatment of shock patients: a prospective randomized study

Vitamin C and thiamine for sepsis: time to go back to fundamental principles